美股市场个股详情

OPGN OpGen

添加自选

0.4420
-0.0280-5.96%

收盘价 05/10 16:00 (美东)

0.4404
-0.0016-0.36%

盘后 19:26 (美东)

558.02万总市值-70市盈率TTM

OpGen股票讨论区

登录发表评论

Stock Region

04/03 02:08

Seasoned Private Investor Secures 19.99% Stake In Medical Company

How David Lazar's Strategic Investment in OpGen Could Affect Your Portfolio.
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...

Sean Parker

03/30 10:56

Going up monday?

$OpGen(OPGN.US)$ 3/29/24 OpGen, Inc. has struck a deal with investor David E. Lazar, who will purchase 3 million shares of Series E Convertible Preferred Stock for $3 million. The initial payment of $200,000 has been made for 200,000 shares, with the rest to follow by May 1, 2024.

Double_Bottom

03/27 22:49

$OpGen(OPGN.US)$ 🚀 for more gain

Double_Bottom

03/27 07:14

$OpGen(OPGN.US)$ double bottom 🚀

Stock Region

03/27 02:33

Medical Company Announces Preferred Stock Acquisition: New CEO Invests $3M

OpGen's New Dawn: David Lazar’s $3M Investment and Leadership Shift - What It Means for You.
In an ambitious move that could significantly alter its trajectory, OpGen, Inc., a key player in the precision medicine industry based in Rockville, Maryland, has announced a strategic shift that puts private investor David Lazar at the helm as the new CEO. This development follows Lazar's substantial investment of $3 million in pr...